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Reduced function of the serotonin transporter (SERT) is associated with increased
susceptibility to anxiety and depression and with type-2 diabetes, which is especially
true in older women. Preference for a “Western diet” (WD), enriched with saturated
fat, cholesterol, and sugars, may aggravate these conditions. In previous studies,
decreased glucose tolerance, central and peripheral inflammation, dyslipidemia,
emotional, cognitive, and social abnormalities were reported in WD-fed young female
mice. We investigated the metabolic, molecular, and behavioral changes associated
with a 3-week-long dietary regime of either the WD or control diet in 12-month-old
female mice with three different Sert genotypes: homozygous (Slc6a4) gene knockout
(Sert−/−: KO), heterozygous (Sert+/−: HET), or wild-type mice (Sert+/+: WT). In the
WT-WD and KO-WD groups, but not in HET-WD-fed mice, most of changes induced
by the WD paralleled those found in the younger mice, including brain overexpression
of inflammatory marker Toll-like receptor 4 (Tlr4) and impaired hippocampus-dependent
performance in the marble test. However, the 12-month-old female mice became obese.
Control diet KO mice exhibited impaired hippocampal-dependent behaviors, increased
brain expression of the serotonin receptors Htr2c and Htr1b, as well as increased
Tlr4 and mitochondrial regulator, peroxisome proliferator-activated receptor gamma-
coactivator-1a (Ppargc1a). Paradoxically, these, and other changes, were reversed
in KO-WD mutants, suggesting a complex interplay between Sert deficiency and
metabolic factors as well as potential compensatory molecular mechanisms that might
be disrupted by the WD exposure. Most, but not all, of the changes in gene expression
in the brain and liver of KO mice were not exhibited by the HET mice fed with either diet.
Some of the WD-induced changes were similar in the KO-WD and HET-WD-fed mice,
but the latter displayed a “rescued” phenotype in terms of diet-induced abnormalities
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in glucose tolerance, neuroinflammation, and hippocampus-dependent performance.
Thus, complete versus partial Sert inactivation in aged mice results in distinct metabolic,
molecular, and behavioral consequences in response to the WD. Our findings show that
Sert+/− mice are resilient to certain environmental challenges and support the concept
of heterosis as evolutionary adaptive mechanism.
Keywords: Sert-deficient mice, Western diet, aging, glucose tolerance, Toll-like receptor 4 (TLR4), serotonin
receptors, obesity, heterosis
INTRODUCTION
Serotonin transporter (SERT), a key element of serotonergic
neurotransmission (Collier et al., 1996; Murphy et al., 2004), is
also involved in the regulation of metabolic processes (Stuart
and Baune, 2012; Giannaccini et al., 2013; Pomytkin et al.,
2015, 2018). In humans, a variant of the upstream regulatory
region of the SERT (SLC6A4) gene, the so-called short (s) allele,
in comparison with long (l) allele is associated with lower
SERT activity and stressed-related vulnerability to anxiety and
depression (Lesch et al., 1996; Greenberg et al., 2000; Caspi et al.,
2010), and also with higher body mass index (BMI) (Sookoian
et al., 2007; Fuemmeler et al., 2008) and incidence of type-2
diabetes (Iordanidou et al., 2010), which are typical for the female
sex and aging (Kautzky-Willer et al., 2016; Khabazkhoob et al.,
2017; Batsis and Zagaria, 2018).
Individuals with metabolic syndrome and obesity display
decreased SERT expression in the brain and periphery
(Giannaccini et al., 2013; Nam et al., 2018). Excessive intake of
a hypercaloric diet, enriched with saturated fat and sugars, was
shown to suppress the binding of hypothalamic SERT in obese
subjects and in insulin-resistant subjects that is independent of
body weight gain (Koopman et al., 2013; Versteeg et al., 2017).
Thus, diminished SERT activity is believed to underlie negative
changes associated with metabolic syndrome (Stuart and Baune,
2012) and in turn, metabolic abnormalities resulting in reduced
SERT function that can contribute to emotional disturbances
(Pomytkin et al., 2015, 2018).
Animal studies support the observations made in humans
concerning the relationship between SERT deficiency and
diabetes-like metabolic changes. Sert-deficient mice (Sert−/−:
KO) were reported to display decreased glucose tolerance,
increased deposition of white adipose tissue that increases with
aging, and late-onset obesity; these changes were particularly
marked in females (Murphy and Lesch, 2008; Üçeyler et al., 2010;
Chen et al., 2012; Zha et al., 2017).
Aging is well known to be associated with compromised
metabolic function (Boemi et al., 2016) and changes in
serotonergic regulation (Rodríguez et al., 2012). Abnormal
distribution of fat in the elderly increases the risk or exacerbates
the negative effects of obesity on metabolic function, including
a decline in insulin sensitivity and glucose tolerance (Morita
et al., 2006; Karakelides et al., 2010). In humans, each decade
results in a 10% decrease in the density of SERT-binding sites
in the brain stem and thalamus (Yamamoto et al., 2002); this
decrease is also found in monkeys and mice (Kakiuchi et al., 2001;
Herrera-Pérez et al., 2013). Aging also results in a decrease in
circulating serotonin and alterations in the densities of the brain
serotonin receptors 5-HT1A, 5-HT2A, and 5-HT1B (Meltzer
et al., 1998; Matuskey et al., 2012) that are more profound in
women (Meltzer et al., 1998).
Despite the evidence of a relationship between genetic SERT
deficiency and diabetes-like metabolic conditions, little is known
about the underlining molecular mechanisms. In the human
population, the combination of genetic SERT deficiency with
an increased intake of the Western diet (WD) during aging
is widespread, but the interactions are difficult to explore.
Mutant animals provide an opportunity to model the interactions
between genotype, diet, and age. Most studies addressing the
impact of decreased SERT function on metabolic regulation
during hypercaloric dietary challenge were performed with young
Sert-deficient mice. For example, Chen et al. (2012) reported
the presence of elevated fasting glucose levels, impaired glucose
tolerance, and insulin resistance in Sert−/− animals exposed to
a high-fat diet for 3 months in male mice. Sert−/− female, but
not male, rats demonstrated increased abdominal fat when fed
either standard chow or a diet high in fat and sugar content
(Homberg et al., 2010).
Concerning the effects of the Western diet and aging on the
metabolic characteristics of Sert heterozygous (Sert+/−: HET)
animals, very limited literature is available. It was reported that
diet-induced metabolic changes in young SERT heterozygous
mice are intermediate in their magnitude, showing impaired
glucose tolerance and insulin resistance, with respect to the
changes in the wild-type and knockout phenotypes (Chen et al.,
2012). However, HET mice are considered to be qualitatively
distinct from Sert−/− animals and closer mimic the short allele
human condition, displaying allelic variation of SERT function.
Substantial differences between two genotypes were described in
a maternal separation and other stress models, in which the HPA
axis was suggested not to affect in the same way in HET and
KO animals (Jiang et al., 2009; van der Doelen et al., 2014). In a
prenatal stress model, HET mice demonstrated signs of superior
stress resilience compared to WT, displaying reduced scores of
anxiety-like behavior and improved cognitive performance (van
den Hove et al., 2011), while other studies showed increased stress
reactivity in KO (Wellman et al., 2007; Bearer et al., 2018).
In the present study, we sought to investigate metabolic,
molecular, and behavioral changes induced by the WD in
aged mice with complete or partial genetic SERT deficit. We
employed a previously validated model that involves feeding
mice with the WD for 3 weeks, and we evaluated metabolic and
neurobiological hallmarks of the WD-induced syndrome in vitro
and ex vivo assays (Strekalova et al., 2015, 2016; Veniaminova
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et al., 2016, 2017, 2020). In this model, impaired glucose
tolerance, increases in cholesterol and leptin blood levels, brain
and liver overexpression of Toll-like receptor 4 (Tlr4), decreased
expression of mitochondrial markers peroxisome proliferator-
activated receptor gamma coactivator 1 (Ppargc1) a and b, and
decreased Sert expression in the brain are all features. These
molecular changes are accompanied by depressive- and anxiety-
like behaviors, signs of impulsivity, lowered sociability, and
cognitive deficits (Strekalova et al., 2015, 2016; Veniaminova
et al., 2016, 2017, 2020). Here, in view of the changes observed
in 5-HT receptor densities in aging and in those with SERT
deficiency, we also studied gene expression of serotonin receptors
Htr1a, Htr1b, and Htr2a in the brain. The expression of the
serotonin receptors Htr2c and Htr6 were also examined owing to
their known role in the regulation of emotionality and metabolic
function (Bickerdike, 2003; Millan, 2005; Heal et al., 2008;
Wesołowska, 2010).
MATERIALS AND METHODS
Animals
Experiments were performed using 12-month-old homozygous
Sert−/− and heterozygous Sert+/− female mice and wild-
type littermates born from heterozygous mutants at the 10th
generation (F10) of backcrossing with C57BL/6J mice; all
genotypes were confirmed by PCR. Mice were housed three to
four per cage during the study, under a reversed 12-h light–
dark cycle (lights on: 21:00 h) with food and water ad libitum
and under controllable laboratory conditions (22 ± 1◦C, 55%
humidity). Laboratory housing conditions and experimental
procedures were set up and maintained in accordance with the
European Communities Council Directive for the care and use of
laboratory animals (2010/63/EU) and approved by the local ethics
committees of C. Bernard University and MSMU (#11–18).
Study Design and Diets
Mice were fed with a standard laboratory diet (control diet,
CD) with an energy content of 3.8 kcal/g, 4.3% of fat (1.3% of
saturated fat) (D18071801, Research Diet Inc., New Brunswick,
NJ, United States) or with a diet containing 0.2% of cholesterol,
21.3% of fat (10.5% of saturated fat), and an energy content
of 4.6 kcal/g, Western diet (D11012302, Research Diet Inc.,
New Brunswick, NJ, United States) for 3 weeks as described
elsewhere (Strekalova et al., 2015, 2016; Veniaminova et al.,
2017). The content of the nutrients in calories and weight and
the ingredients are indicated in Supplementary Table S1. Body
weight and intake of diet and water were monitored weekly (on
days 1, 8, 15, and 21). Daily intake of calories and water was
normalized to body weight.
After a 3-week period of dietary challenge, a cohort of mice
was studied, in a novel cage, with O-maze test, depressive-
like behaviors in tail suspension and forced swim tests, in the
pellet displacement tube (marble) test, a rodent paradigm for
a hippocampus-dependent performance (Deacon et al., 2002;
Strekalova and Steinbusch, 2010), and a glucose tolerance test
(Figure 1A). Another cohort of animals was exposed to the same
dietary conditions and sacrificed and dissected for the analysis of
gene expression (Figure 1B). During the testing period (days 20
to 23), animals from the WD group received WD and mice from
the CD group were fed with standard diet. Six to seven mice per
group were used in each study.
Behavioral Testing
All behavioral tests were carried out during the active period of
the animals’ light cycle (09:00–21:00); behavior was recorded and
scored offline. The experimenter was blind to the identity of the
diet used and the genotype.
Novel Cage Test
The novel cage test was performed to assess the exploration
of a new environment. Mice were introduced into a standard
plastic cage (21 × 27 × 14 cm), under 5-lx lighting. The
number of exploratory rears was counted for the first minute
of the test by visual observation, as described elsewhere
(Costa-Nunes et al., 2015).
Elevated O-Maze
The maze consisted of a black circular path (runway width
5.5 cm, diameter 46 cm) that was placed 20 cm above the floor.
Illumination intensity was 5 lx. Two opposing compartments
were protected by the walls (height 10 cm). Mice were introduced
to one of the two closed compartments. Latency to exit to the
anxiety-related open compartments of the maze was scored, as
described elsewhere (Strekalova et al., 2015).
Tail Suspension Test
Mice were subjected to the tail suspension by being hung by
their tails with adhesive tape to a rod 50 cm above the floor
for 6 min, as described elsewhere (Malatynska et al., 2012).
The lighting intensity on the height of the mouse position was
25 lx. The trials were recorded by a video camera positioned
directly in front of the mice, while the experimenter observed the
session from a distance in a dark area of the experimental room.
The latency of the first episode of immobility was scored. In
accordance with the commonly accepted criteria of immobility,
the immobility behavior was defined as the absence of any
movements of the animals’ head and body. The scoring method
was previously validated using CleverSys software (CleverSys,
Reston, VA, United States) and Noldus software (Wageningen,
Netherlands) (Malatynska et al., 2012).
Swim Test
This test was carried out as described previously (Strekalova
et al., 2015). Mice were placed into a plastic transparent cylinder
(Ø 17 cm) filled with water (+23◦C, water height 13 cm, and
height of cylinder 20 cm) under red lighting. The total duration
of floating behavior, defined by the absence of any directed
movements of the animals’ head and body, was scored offline
during the 6-min period. Latency to float was evaluated as well.
The scoring method was previously validated using CleverSys
software (CleverSys, Reston, VA, United States) and Noldus
software (Wageningen, Netherlands) (Malatynska et al., 2012).
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FIGURE 1 | Experimental design. (A) Study of the effects of 3-week “Western diet” (WD) feeding of wild-type (WT), heterozygous (HET), and knockout (KO) mice on
behavior in tail suspension, novel cage, O-maze, food displacement, forced swim, and glucose tolerance tests. (B) Study of the effects of 3-week WD feeding of WT,
HET, and KO mice on gene expression in the brain and liver.
Pellet Displacement Tube (Marble) Test
All experimental groups were tested for pellet displacement in a
tube test as described elsewhere (Deacon et al., 2002; Strekalova
and Steinbusch, 2010). A tendency to displace small objects, for
example, small stones or food pellets from a tube inside the cage,
is species specific in mice and was demonstrated to depend on
an intact hippocampal formation (Deacon et al., 2002). Using a
paper tube (internal diameter 4 cm, length 10 cm) filled with 20
food pellets and placed in the cage (21 × 27 × 14 cm), the time
required for 50% emptying of the tube was recorded.
Glucose Tolerance Test
Oral glucose tolerance test (OGTT) was performed as described
elsewhere (Veniaminova et al., 2017, 2020). The test mice were
fasted overnight for 18 h, beginning at 1600. Thereafter, a glucose
solution (2 g/kg, 1.8 g/L) was delivered by oral gavage, and blood
was sampled from the tail vein. Samples were obtained prior
to glucose administration at the time point 0 and 5, 15, 30,
60, 90 min afterward. The level of blood glucose was analyzed
using the OneTouch UltraEasy glucometer and strips (LifeScan
OneTouch, Dubai, United Arab Emirates). Fasting blood glucose
concentrations and the area under the curve (AUC) for the whole
test period and for the period between 60 and 90 min after glucose
load were analyzed.
Tissue Dissection
Mice were terminally anesthetized with isoflurane inhalation
for a subsequent material collection. The brain of each mouse
was perfused with saline and dissected as described elsewhere
(Couch et al., 2013). The following brain structures were
isolated according to Paxinos and Franklin’s the “Mouse brain in
stereotaxic coordinates”: prefrontal cortex (interaural 6.14–5.14),
hypothalamus (interaural 3.22–0.88), hippocampus (interaural
2.22–1.00), and dorsal raphe region (interaural -0.56–1.40).
Tissue was stored at−80◦C until use.
RNA Extraction and qR T-PCR
Total mRNA was extracted using the RNeasy Mini Kit (Qiagen,
Venlo, Netherlands). First-strand cDNA synthesis was performed
using High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Waltham, MA, United States); 1 µg of total
RNA was converted into cDNA. Quantitative PCR for the
genes of interest (Htr1a, Htr1b, Htr2a, Htr2c, Htr6, Ppargc1a,
Ppargc1b, Tlr4) and the reference genes (glyceraldehyde 3-
phosphate dehydrogenase (Gapdh), β-actin (Actb), and β-2
microglobulin (B2m), was performed using the SYBR Green
PCR Master Mix (Applied Biosystems) and QuantStudio
7 Flex Real-Time PCR System (Applied Biosystems). The
sequences of primers used are indicated in Supplementary
Table S2. The reference genes for normalization were tested
for stability using the RefFinder software. The results of the
qRT-PCR measurement were expressed as Ct values, and
the comparative Ct method was used. Data are given as
expression folds compared to the mean expression values
in WT mice fed a control diet as described elsewhere
(Couch et al., 2013).
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Statistics
Data were analyzed using GraphPad Prism version 8.01 (San
Diego, CA, United States). For comparison of the six groups, two-
way ANOVA followed by Tukey’s post hoc test was used. One-way
ANOVA followed by post-test for trend was used for analysis
of genotype body weight data at baseline. For comparison of a
group mean of 100%, one sample t test was performed. Three-
way ANOVA analysis was performed using IBM SPSS Statistics
23 (Armonk, NY, United States). The level of significance was set
at p < 0.05. Data were presented as mean± SEM or mean.
RESULTS
Western Diet and SERT Deficiency Affect
Metabolic Parameters
There was a significant difference in body weight at baseline
between the Sert genotypes (F = 4.547, p = 0.016, one-way
ANOVA). A linear increase in body weight from the WT to
KO group (p = 0.005, post-test for trend) (Figure 2A) was
found. Two-way ANOVA revealed a significant effect of the diet
type on the body weight measured both in absolute values and
normalized to basal values (p < 0.05) (Table 1) after 3 weeks
of feeding as measured on day 21. The body weight of WT,
HET, and KO mice fed with WD was increased compared with
the respective genotype-matched control groups (absolute body
weight values: p = 0.010, p = 0.001, and p = 0.005, respectively,
Tukey’s test; normalized to basal values: p < 0.001, p < 0.001, and
p< 0.001, respectively, Tukey’s test) (Figures 2B,C). A significant
interaction between the diet type and the day of the experiment
and a significant effect of the genotype were found for body
weight changes (F = 6.452, p < 0.001, and F = 28.827, p < 0.001,
three-way ANOVA). No differences between the groups were
found on days 1 and 8. On day 15, body weight was increased
in HET-WD mice compared to control HET mice (p = 0.014,
Tukey’s test) (Figure 2D); on day 21, all Sert genotype groups fed
with WD displayed increased body weight compared to controls
(p = 0.044 for WT-WD, p = 0.002 for HET-WD, p = 0.020 for KO-
WD, Tukey’s test). Thus, 3-week WD feeding resulted in body
weight increase in all Sert genotypes.
As revealed by the three-way ANOVA, there was a significant
interaction between genotype, diet, and experimental day for
daily diet calorie intake (F = 5.944, p < 0.001). During the first
week of the experiment, daily calorie intake was increased in WT,
HET, and KO mice fed with WD compared to mice fed with CD
(p < 0.001, p < 0.001, and p < 0.001, respectively, Tukey’s test)
(Figure 2E). Then, during the second week, calorie intake was
decreased in KO mice fed with CD compared to WT and HET
fed with CD (p = 0.027 and p = 0.030, respectively, Tukey’s test).
During the third week, calorie intake was decreased in KO-CD
mice compared to HET-CD (p = 0.0231, Tukey’s test). Similar
results were obtained for daily diet intake measured in grams
per kg of body weight (Supplementary Figure S1). Significant
interaction between genotype and diet and experimental day and
diet was found for daily water intake (F = 15.487, p < 0.001,
and F = 20.020, p < 0.001, respectively, three-way ANOVA).
During the first week, water intake was decreased in HET-WD
and KO-WD mice compared to WT-WD (p = 0.016 and p = 0.018,
respectively, Tukey’s test) (Figure 2F). During the second and
third weeks, HET and KO groups fed with WD showed decreased
water intake compared to the respective genotype-matched
groups fed with CD (HET-WD: p < 0.001 and p < 0.001, KO-
WD: p = 0.0003 and p < 0.0001, respectively, Tukey’s test). In that
way, Sert deficiency resulted in a decreased diet intake in KO mice
and decreased water intake in HET and KO after WD exposure.
We found significant effects of the diet type and the genotype
(two-way ANOVA, p < 0.05) (Table 1) on the fasting blood
glucose levels. Glucose levels after 18 h of food deprivation
were decreased in KO mice fed with WD compared to KO fed
with CD (p = 0.024, Tukey’s test) (Figure 3A). Fasting blood
glucose levels normalized to the respective genotype-matched
CD group values were also decreased in KO-WD compared to
100% (t = 3.528, p = 0.0243, one sample t test) (Figure 3B).
Two-way ANOVA analysis demonstrated a significant diet effect
(p < 0.05) (Table 1 and Figure 3C) on the area under the curve
(AUC) calculated for the glucose tolerance curve (Figure 3D).
Post hoc analysis revealed a significant increase in AUC in WT
and KO mice fed with WD compared to the respective control
groups (p = 0.021 and p = 0.028, respectively, Tukey’s test).
No differences in AUC were found between the HET-CD and
HET-WD groups. There was a significant diet effect on the AUC
calculated for the period between 60 and 90 min after glucose load
(p< 0.05) (Table 1). This parameter was significantly increased in
the KO-WD compared to KO-CD group (p = 0.021, Tukey’s test)
(Figure 3E). These results indicate that the impairment in glucose
tolerance due to feeding with WD was exacerbated in the KO
mice in comparison to the WT but was absent in the HET group.
Effects of Western Diet and SERT
Deficiency on the Expression of Markers
of Mitochondrial Activity and Tlr4 in the
Brain and Liver
A significant interaction between the genotype and diet was
shown in mRNA levels of Ppargc1a in the hypothalamus
and hippocampus (two-way ANOVA, p < 0.05) (Table 2
and Supplementary Figure S2). The effect of genotype was
significant in the dorsal raphe region and prefrontal cortex
(p < 0.05) (Table 2). Post hoc analysis revealed a significant
increase in Ppargc1a expression levels in the hypothalamus and
the prefrontal cortex of KO-CD in comparison to the WT
and HET mice fed with CD (p = 0.039 and p = 0.045 for
hypothalamus and p = 0.002 and p = 0.006 for prefrontal
cortex, Tukey’s test) (Figure 4A). Ppargc1a expression in the
hypothalamus of KO-WD was decreased in comparison to KO-
CD (p = 0.045, Tukey’s test).
Two-way ANOVA revealed a significant genotype effect on
mRNA levels of Ppargc1b in the hypothalamus (p < 0.05)
(Table 2). In addition, there was a significant diet effect in the
dorsal raphe region and prefrontal cortex (p < 0.05) (Table 2)
on the expression of Ppargc1b. No differences were found in the
hippocampus (Supplementary Figure S2). Ppargc1b expression
levels were decreased in the hypothalamus in the KO and HET
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FIGURE 2 | Effects of Western diet feeding on body weight and food and water intake. (A) Basal body weight of mice from different serotonin transporter (Sert)
genotypes: WT, HET, KO. (B,C) Body weight after 3-week housing on WD or CD in absolute values and normalized to basal body weight. (D) Dynamics of the
mouse body weight measured every week during the experiment. Mice fed with WD demonstrated an increase in body weight during the study. (E,F) Diet and water
intake. *p < 0.05, one-way ANOVA and post-test for trend panel (A) or two-way ANOVA and Tukey’s test (B–F), six to seven animals per group were used. Data are
shown as mean ± SEM (A–C,E,F) or mean (D).
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TABLE 1 | Two-way ANOVA results for statistical analysis of metabolic parameters.
Metabolic parameters
Parameter Interaction, F Interaction, p Genotype, F Genotype, p Diet, F Diet, p
Body weight on D21, absolute values 0.09742 0.9075 8.510 0.0012 37.98 <0.001
Body weight on D21, normalized to basal values 0.8320 0.4450 0.9820 0.3863 70.65 <0.001
Fasting blood glucose level 1.897 0.1710 7.369 0.0030 6.514 0.0172
Area under the curve (AUC) for glucose tolerance test 1.343 0.2808 1.053 0.3651 9.242 0.0058
AUC for glucose tolerance test, 60–90 min 2.392 0.1139 0.3612 0.7007 9.357 0.006
F and p values are shown for interaction between genotype and diet, for genotype effect and for diet effect. p-values <0.05 are marked in bold.
FIGURE 3 | Effects of Western diet feeding on glucose tolerance. (A) Fasting blood glucose level after 18 h of food deprivation. WD decreased fasting glucose level
in KO mice. (B) WD group basal glucose levels normalized to respective genotype group fed with CD values in comparison with 100%. (C) Area under glucose
tolerance curve. WD increased area under the curve (AUC)_ in WT and KO mice. (D) Glucose tolerance curve. (E) Area under glucose tolerance curve for the period
between 60 and 90 min. *p < 0.05, two-way ANOVA and Tukey’s test (A,C,E) or one sample t test vs. 100% (B), six to seven animals per group were used. Data
are shown as mean ± SEM (A–C, E) or mean (D).
mice when compared to the WT mice (p = 0.0376 and p = 0.0095,
respectively, Tukey’s test) (Figure 4B).
We found a significant effect of the genotype on mRNA levels
of Tlr4 in the hypothalamus and the prefrontal cortex (two-
way ANOVA, p < 0.05) (Table 2). Also, there was a significant
diet effect in the dorsal raphe region (p < 0.05) (Table 2). No
differences were found in the hippocampus (Supplementary
Figure S2). Post hoc analysis showed an increase in Tlr4
expression levels in the hypothalamus of KO mice compared to
WT and HET groups (p < 0.001 and p = 0.005, respectively,
Tukey’s test) (Figure 4C). In addition, a significant increase
in Tlr4 expression was detected in the dorsal raphe region in
WT and KO mice fed with WD compared to groups fed with
CD (p = 0.042 and p = 0.040, respectively, Tukey’s test) but
not in HET mice, and in the prefrontal cortex in the KO-WD
group compared to the WT-WD group (p = 0.0403, Tukey’s
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TABLE 2 | Two-way ANOVA results for statistical analysis of Ppargc1a and b and Tlr4 gene expression.
Brain gene expression
Gene Brain structure Interaction, F Interaction, p Genotype, F Genotype, p Diet, F Diet, p
Ppargc1a HT 6.003 0.0054 1.799 0.1793 0.1123 0.7394
DR 0.3308 0.7205 7.713 0.0017 3.750 0.0609
HIP 3.455 0.0418 1.745 0.1883 2.065 0.1589
PF 2.001 0.1492 10.46 0.0002 2.956 0.0937
Ppargc1b HT 0.2827 0.7554 5.436 0.0085 0.00613 0.9380
DR 0.1146 0.8921 0.9017 0.4166 5.301 0.0284
HIP 0.1623 0.8508 2.629 0.0856 0.01598 0.9001
PF 0.3177 0.7301 0.03676 0.9639 5.088 0.0313
Tlr4 HT 0.01194 0.9881 13.47 <0.0001 0.04089 0.8409
DR 2.007 0.1509 4.994 0.0130 11.08 0.0022
HIP 0.6018 0.5529 1.317 0.2800 0.2996 0.5874
PF 1.370 0.2678 5.296 0.0100 2.930 0.0961
Liver gene expression
Ppargc1a 6.052 0.0056 6.143 0.0053 1.733 0.1969
Ppargc1b 9.094 0.0007 10.46 0.0003 4.501 0.0412
Tlr4 1.696 0.1978 0.2381 0.7893 1.668 0.2048
F and p values are shown for interaction between genotype and diet, for genotype effect, and for diet effect. HT, hypothalamus; DR, dorsal raphe region; HIP, hippocampus;
PF, prefrontal cortex. p-values <0.05 are marked in bold.
test). Thus, the most prominent increase in Tlr4 expression was
found in KO fed WD. No effect of WD on Tlr4 expression was
observed in HET mice.
In the liver, there was a significant interaction between
genotype and diet on the expression of Ppargc1a and Ppargc1b
(two-way ANOVA, p < 0.05) (Table 2). Ppargc1a and Ppargc1b
expression levels in the liver were decreased in WT-WD
compared to WT-CD (p = 0.026 and p = 0.002, respectively,
Tukey’s test) (Figure 4D), and in HET and KO mice fed with CD
compared to the WT mice fed with CD (p = 0.011, p = 0.002 and
p < 0.001, p < 0.001, respectively, Tukey’s test). No differences
between the groups were found in the Tlr4 expression in the liver.
Changes in Brain Expression of
Serotonin Receptors by Western Diet
and SERT Deficiency
Two-way ANOVA analysis demonstrated a significant genotype
effect on the Htr1a mRNA levels in the dorsal raphe region and
prefrontal cortex (p < 0.05) (Table 3). In addition, a significant
effect of diet was shown in the prefrontal cortex (p < 0.05)
(Table 3). Htr1a expression levels in the dorsal raphe region were
decreased in the HET and KO mice compared to the WT mice
(p < 0.001 and p = 0.011, respectively, Tukey’s test) (Figure 5A).
There was a significant interaction between the genotype and
diet in mRNA levels of Htr2a in the hippocampus (two-way
ANOVA, p < 0.05) (Table 3). Htr2a expression was elevated
in the hippocampus of the KO-CD mice compared to the WT-
CD and HET-CD mice (p = 0.001 and p = 0.006, Tukey’s
test) (Figure 5B).
A significant interaction between genotype and diet in mRNA
levels of Htr1b receptor was found in the hypothalamus, dorsal
raphe region, and prefrontal cortex (two-way ANOVA, p < 0.05
(Table 3) but not in hippocampus. Post hoc analysis revealed
a significant increase in Htr1b expression in the hypothalamus,
dorsal raphe region, and prefrontal cortex of the KO-CD group
compared to the WT-CD and HET-CD groups (p = 0.040 and
p = 0.020 for the hypothalamus, p < 0.001 and p < 0.001 for the
dorsal raphe region, and p = 0.001 and p = 0.001 for the prefrontal
cortex, Tukey’s test) (Figure 5C). In addition, Htr1b expression
levels were decreased in the hypothalamus and the dorsal raphe
region of the KO mice fed with WD in comparison to the KO
mice fed with CD (p = 0.006 for the hypothalamus, p = 0.002 for
the dorsal raphe region, Tukey’s test).
We found a significant interaction between genotype and diet
in mRNA levels of the Htr2c receptor in the hypothalamus, dorsal
raphe region, and prefrontal cortex (two-way ANOVA, p < 0.05)
(Table 3), but not in hippocampus. Htr2c expression levels in
the hypothalamus, dorsal raphe region, and prefrontal cortex
of the KO mice fed with CD were increased compared to the
WT and HET mice fed with CD (p < 0.001 and p < 0.001
for the hypothalamus, p = 0.003 and p < 0.001 for the dorsal
raphe region, and p = 0.003 and p = 0.002 for the prefrontal
cortex, Tukey’s test) (Figure 5D). Decreased Htr2c expression
levels in the hypothalamus and the dorsal raphe region of KO-
WD compared to KO-CD were also detected (p = 0.002 for the
hypothalamus, p = 0.003 for the dorsal raphe region, Tukey’s test).
There was a significant effect of genotype on mRNA levels
of Htr6 receptor in the hippocampus and the dorsal raphe
region (p < 0.05) (Table 3). In the hippocampus, Htr6
expression was increased in the HET mice compared to the WT
(p = 0.029, Tukey’s test) (Figure 5E). Htr6 expression levels were
significantly decreased in the dorsal raphe region of the HET and
KO mice compared to the WT mice (p = 0.010 and p = 0.023,
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FIGURE 4 | Effects of Western diet and SERT deficiency on brain and liver gene expression of markers of mitochondrial activity and Tlr4. (A–C) Ppargc1a,
Ppargc1b, and Tlr4 expression in hypothalamus, dorsal raphe region, and prefrontal cortex. Tlr4 expression in dorsal raphe region was significantly increased in WT
and KO, but not HET mice fed with WD, compared to respective groups fed with CD. (D) Ppargc1a, Ppargc1b, and Tlr4 expression in the liver. *p < 0.05, two-way
ANOVA and Tukey’s test, main genotype effect is marked with braces, six to seven animals per group were used. Data are shown as mean ± SEM.
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TABLE 3 | Two-way ANOVA results for statistical analysis of serotonin receptor gene expression.
Brain gene expression
Gene Brain structure Interaction, F Interaction, p Genotype, F Genotype, p Diet, F Diet, p
Htr1a HT 0.07188 0.9308 2.915 0.0664 1.419 0.2409
DR 0.3828 0.6850 8.898 0.0008 0.00130 0.9715
HIP 0.5541 0.5792 2.066 0.1407 0.02632 0.8720
PF 0.8123 0.4523 6.690 0.0035 9.665 0.0038
Htr2a HT 0.4899 0.6165 0.8927 0.4180 0.8340 0.3669
DR 0.5235 0.5971 2.932 0.0669 0.2083 0.6510
HIP 3.485 0.0408 9.263 0.0005 1.188 0.2827
PF 0.3957 0.6759 2.289 0.1152 0.2406 0.6266
Htr1b HT 14.07 <0.0001 1.108 0.3407 0.7577 0.3895
DR 8.429 0.0010 13.71 <0.0001 2.331 0.1358
HIP 0.7293 0.4889 0.9170 0.4084 0.4561 0.5035
PF 4.426 0.0189 10.70 0.0002 1.309 0.2600
Htr2c HT 9.803 0.0004 10.14 0.0003 0.6533 0.4240
DR 5.308 0.0097 10.55 0.0003 6.429 0.0158
HIP 0.2895 0.7503 1.057 0.3574 0.6697 0.4183
PF 6.560 0.0036 6.111 0.0050 0.4158 0.5229
Htr6 HT 0.2326 0.7936 0.3814 0.6856 0.07229 0.7895
DR 0.05340 0.9481 5.580 0.0079 0.4079 0.5272
HIP 0.2349 0.7918 4.290 0.0211 0.3645 0.5497
PF 1.420 0.2546 0.2677 0.7666 0.09352 0.7615
F and p values are shown for interaction between genotype and diet, for genotype effect and for diet effect. HT, hypothalamus; DR, dorsal raphe region; HIP, hippocampus;
PF, prefrontal cortex. p-values <0.05 are marked in bold.
Tukey’s test). In that way, the expression of Htr1b, Htr2a, and
Htr2c was increased in the KO group fed with CD. Feeding with
WD inversed these changes. Sert-deficient mice, irrespective of
the diet, demonstrated a decreased Htr1a and Htr6 expression in
the dorsal raphe region.
Western Diet and SERT Deficiency
Affected Emotionality and
Hippocampus-Dependent Performance
A comparison of exploratory rearing activity in the novel cage test
during the first minute of the test by two-way ANOVA showed
a significant genotype effect on the number of rears (p < 0.05)
(Table 4). The number of rears was decreased in the WD-fed
KO group in comparison to the WD-fed WT and HET mice
(p = 0.0034 and p = 0.0441, respectively, Tukey’s test) (Figure 6A),
suggesting a reduced exploration in the KO mice fed with WD.
In the O-maze test, there was a significant diet effect (two-
way ANOVA, p < 0.05) (Table 4) on the latency to exit to open
arm. This parameter was decreased in the KO mice fed with WD
compared to the KO group fed with CD (p = 0.0095, Tukey’s test)
(Figure 6B), which could be interpreted as a sign of increased
impulsivity in the KO-WD group.
In the tail suspension test, two-way ANOVA revealed a
significant diet effect (two-way ANOVA, p < 0.05) (Table 4)
on the latency to immobility (Figure 6C). While no significant
differences were observed between the groups, there was a
trend of decreasing latency to immobility in the groups fed
with WD compared to the respective genotype-matched groups
fed with CD. Significant genotype and diet effects (p < 0.05)
(Table 4) were found in the latency to float and duration of
floating in the swim test. Post hoc analysis revealed a significant
decrease in the latency to floating in the HET mice fed WD
and the KO mice fed CD in comparison to the CD-fed HET
group (p = 0.0276 and p = 0.0356, respectively, Tukey’s test)
(Figure 6D). Total duration of floating was increased in the
WD-fed WT, HET, and KO groups compared to the CD-fed
mice (p = 0.049, p = 0.030, p < 0.001, respectively, Tukey’s
test) (Figure 6E). Correlation analysis revealed no significant
correlation between mouse body weight and duration of floating,
latency to floating, and latency to immobility (p> 0.05). This data
suggests that WD feeding induces depressive-like behavior in all
Sert genotypes.
In the pellet-displacement test, there was a significant
interaction between the genotype and diet type (p < 0.05)
(Table 4) in the latency of 50% performance accomplishment.
The latency of 50% performance accomplishment was increased
in WT-WD and KO-WD mice but not in HET-WD compared to
mice fed with CD (p < 0.001 and p = 0.037, respectively, Tukey’s
test) (Figure 6F). In addition, this parameter was increased in
the KO group fed with CD compared to the WT-CD and HET-
CD (p < 0.001 and p = 0.001, respectively, Tukey’s test) as
well as in the KO group fed with WD compared to the WT-
WD and HET-WD (p < 0.001 and p < 0.001, respectively,
Tukey’s test). Results of this test suggest that complete Sert
deficiency impairs hippocampal-dependent performance. The
same effect was observed in WT and KO but not in HET
mice fed with WD.
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FIGURE 5 | Changes in brain expression of serotonin receptors by Western diet and SERT deficiency. (A,B) Htr1a and Htr2a expression in hypothalamus, dorsal
raphe region, hippocampus, and prefrontal cortex. (C,D) Htr1b and Htr2c expression in the brain. KO mice fed with CD compared to WT and HET mice fed with CD
displayed significant increase in Htr1b and Htr2c expression levels in hypothalamus, dorsal raphe region, and prefrontal cortex. Compared to KO mice fed with CD,
KO mice fed with WD demonstrated significant decrease in Htr1b and Htr2c expression levels in hypothalamus and dorsal raphe region. (E) Htr6 expression in
hypothalamus, dorsal raphe region, hippocampus, and prefrontal cortex. *p < 0.05, two-way ANOVA and Tukey’s test, main genotype effect is marked with braces,
six to seven animals per group were used. Data are shown as mean ± SEM.
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TABLE 4 | Two-way ANOVA results for statistical analysis of behavioral parameters.
Behavioral parameters
Parameter Interaction, F Interaction, p Genotype, F Genotype, p Diet, F Diet, p
Number of rears, 1st min 3.336 0.0502 5.034 0.0136 1.680 0.2055
Latency to exit lit arm 1.937 0.1652 1.888 0.1724 8.482 0.0074
Latency to float 1.080 0.3556 7.790 0.0025 13.34 0.0013
Duration of floating 1.303 0.2903 3.514 0.0459 33.47 <0.0001
Latency to immobility 0.08797 0.9161 1.601 0.2216 10.86 0.0029
Latency of 50% accomplishment in tube test 4.210 0.0192 29.07 <0.0001 27.17 <0.0001
F and p values are shown for interaction between genotype and diet, for genotype effect and for diet effect. p-values <0.05 are marked in bold.
FIGURE 6 | Western diet and SERT deficiency affected behavioral parameters, especially in KO mice. (A) Number of rears during the fires minute in novel cage test.
KO group fed with WD compared to WT and HET mice fed with WD showed decrease in the number of rears. (B) Latency to exit to open arm in O-maze. The
latency to exit to open arm was decreased in the KO mice fed with WD compared to the KO group fed with CD. (C) Latency to immobility in tail suspension test.
(D) Latency to floating in swim test. (E) Duration of floating in swim test. Compared to groups fed with CD, mice from all Sert genotypes fed with the WD
demonstrated increased duration of floating in swim test. (F) Latency of 50% performance accomplishment in the pellet-displacement test. WT and KO mice fed
with WD in comparison with mice fed with CD demonstrated increased latency of 50% performance accomplishment. This parameter was also significantly
increased in KO mice fed with CD and WD compared to respective diet WT and HET groups. *p < 0.05, two-way ANOVA and Tukey’s test, six to seven animals per
group were used. Data are shown as mean ± SEM.
Overall, our data indicate that there is a distinct metabolic,
molecular, and behavioral effects of the WD on aged mice with
complete versus partial Sert inactivation (Table 5), which suggest
that Sert+/− mice are resilient to several key negative effects of
the WD (Table 6).
DISCUSSION
Our results reveal that the effects of the WD are, in general,
exacerbated in aged Sert KO mice in relation to the previously
established metabolic, molecular, and behavioral changes. In
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TABLE 5 | Effects of Western diet in groups with different Sert expression.
Group
parameter
WT-WD
vs.
WT-CD
HET-WD
vs.
HET-CD
KO-WD
vs.
KO-CD
Metabolism
Body weight ↑ ↑ ↑
Food intake, week 1 ↑ ↑ ↑
Water intake, weeks 2 and 3 = ↓ ↓
Fasting blood glucose = = ↓
Glucose tolerance ↓ = ↓↓
Liver gene expression
Ppargc1a and b ↓ = =
Brain gene expression
Ppargc1a, HT = = ↓
Tlr4, DR ↑ = ↑
Htr1b, HT and DR = = ↓
Htr2c, HT and DR = = ↓
Behavior
Rearing in novel cage = = ↓
Latency to exit open arm in O-maze = = ↓
Duration of floating in swim test ↑ ↑ ↑
Latency to float in swim test = ↓ =
Latency of 50% performance
accomplishment in pellet
displacement test
↑ = ↑↑
Most of the metabolic, molecular, and behavioral changes found in WT-WD mice
were exacerbated in KO-WD. Some of the effects of the WD were absent in the HET
mice compared to the WT and KO. HT, hypothalamus; DR, dorsal raphe region; HIP,
hippocampus; PF, prefrontal cortex. Body weight was analyzed after 3 weeks of
WD feeding. Food intake was measured in kcal/g of body weight, water intake—in
ml/g of body weight.
particular, the key hallmarks of the WD-induced syndrome
that were observed in the Sert−/− mice and WT controls
included decreased glucose tolerance, brain expression of Tlr4,
and disrupted hippocampus-dependent performance, but these
were not observed in the Sert+/− animals. Surprisingly, all
the genotypes challenged with WD displayed similar changes
in weight gain, depressive-like behavior, and suppressed the
expression of Ppargc1a and Ppargc1b in the liver. Most
molecular changes that occurred in the two Sert-deficient
genotypes developed regardless of diet. These observations will
be discussed, in turn, below.
The present study on aged mice has, in general, replicated
the principal findings reported for young mice fed the WD,
such as impaired glucose tolerance, altered expression of Tlr4,
Ppargc1a, and Ppargc1b (Strekalova et al., 2015, 2016), and signs
of emotional and cognitive abnormalities (Strekalova et al., 2015,
2016; Veniaminova et al., 2016, 2017, 2020). In comparison with
young mice, aged animals exposed to WD gained weight and
exhibited less profound changes in the expression of markers of
inflammation and mitochondrial function. This is likely due to
age-related alterations in the expression of these genes (Scarpulla,
2002; Letiembre et al., 2007; Burgueño et al., 2013). The aged
mice displayed a prolonged increase in intake in the amount of
calories after the switch to the highly caloric WD, which lasted
for at least one week instead of 3 days in young mice (Strekalova
TABLE 6 | Comparison of HET, KO, and WT mice fed with the control diet.
Group
parameter
HET-CD
vs.
WT-CD
KO-CD
vs.
WT-CD
Metabolism
Basal body weight ↑ ↑↑
Food intake, weeks 2 and 3 = ↓
Liver gene expression
Ppargc1a and b ↓ ↓
Brain gene expression
Ppargc1a, HT and PF = ↑
Ppargc1b, HT ↓ ↓
Tlr4, HT = ↑
Htr1a, DR ↓ ↓
Htr2a, HIP = ↑
Htr1b, HT, DR and PF = ↑
Htr2c, HT, DR and PF = ↑
Htr6, DR ↓ ↓
Htr6, HIP ↑ =
Behavior
Latency of 50% performance accomplishment
in pellet displacement test
= ↑
While some metabolic, molecular, and behavioral differences with WT were similar
in HET and KO, KO mice demonstrated a more distinguishable phenotype. HT,
hypothalamus; DR, dorsal raphe region; HIP, hippocampus; PF, prefrontal cortex.
Food intake was measured in kkal/g of body weight.
et al., 2015). This is in accordance with the well-described age-
related dysregulation of consummatory behavior and metabolic
processes (Gill et al., 2015) in the WD model.
The aged Sert−/− mice fed a WD displayed greater
changes in most of the diet-induced abnormalities that
were found in the WT controls, including impairment of
glucose tolerance, behavioral despair, suppressed novelty
exploration and hippocampus-dependent performance,
impulsivity in the O-maze, and brain over-expression of
Tlr4. At the end of the experiment, in comparison with other
genotypes, Sert−/− mice displayed a significant decrease
in the intake of calories and lowered the blood levels of
fasting glucose after being fed the WD. Similar findings were
obtained after a 24-week exposure of hamsters to a high-
fat diet (Guo et al., 2016) and seemed to be underpinned
by the facilitated conversion of blood glucose to lipids, in
corollary to the present study, and Sert−/− mice revealed
an increased glucose absorption in the bowel (Greig et al.,
2017). Previous work with WD-fed 6-month-old male
Sert−/− mice reported the opposite effects (Chen et al.,
2012), but this appears to be owing to a sex-related bias
(Comhair et al., 2011).
Notably, the finding here that there was reduced energy
intake in Sert−/− mutants rules out the possibility that
their weight gain was due to increased diet intake. Instead,
the metabolic changes described in the Sert−/− genotype
are likely to be caused by functional disturbances in the
hypothalamic regulation of intake, which might be related
to the overexpression of Tlr4 in this part of the brain.
The activation of TLR4 by long-chain saturated fatty acids
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(lcSFA) was argued to be a direct trigger of inflammatory
mechanisms during excessive consumption of WD-like diets,
but lcSFAs are not TLR4 agonists and seem to provide a
second hit of activation that is dependent upon prior TLR4
activation. However, lcSFAs, such as palmitate, can induce
JNK activation in macrophages and are likely to activate
microglia and increase TLR4 expression (Lancaster et al., 2018).
Generalized brain overexpression of the TLR4 on the gene
and protein levels was shown in the WD-exposed young
mice (Strekalova et al., 2015). Pro-inflammatory changes and,
particularly, elevated expression of Tlr4 in the hypothalamus,
a primary brain area regulating metabolism (Kahn and Flier,
2000), were shown to affect insulin receptor signaling (Wellen
and Hotamisligil, 2003; Benomar et al., 2013; Zhao et al.,
2017). Accumulating evidence indicates that neuroinflammatory
processes of various causes markedly affects insulin receptor
sensitivity (Savage et al., 2001; Olefsky and Glass, 2010). The
dysregulation of insulin receptor-mediated signaling can result
in the suppression of mitochondrial function and decreased
expression of Ppargca1 and PPargcb1 that is reported in the
present study and elsewhere (Savage et al., 2001; Scarpulla,
2002; Burgueño et al., 2013; Strekalova et al., 2016). The latter
results in impaired glucose tolerance, decreased metabolic rate,
and obesity (Kahn and Flier, 2000; Wellen and Hotamisligil,
2003). Thus, a close functional relationship between decreased
SERT function, pro-inflammatory changes, and insulin resistance
is supported by the existing literature (Haub et al., 2010;
Pomytkin et al., 2015, 2018).
Naïve Sert−/− mice displayed increased brain expression
of Ppargc1a, Htr2a, Htr1b, and Htr2c that were not found
in other genotypes and were “reversed” in WD-fed animals.
Given the previously demonstrated association between most
of these receptors with obesity and aging (Lee et al., 1998;
Meltzer et al., 1998; Simansky and Nicklous, 2002; Nonogaki
et al., 2006; Ridderstråle et al., 2006), it seems reasonable to
hypothesize that these changes may be adaptive changes, and
that the WD disrupts these compensatory changes resulting
in aggravation of metabolic and behavioral abnormalities in
Sert−/− mutants. Expression of several genes were found to
be similarly, altered in both Sert−/− and Sert+/− genotypes
regardless of the diet composition. Decreases in expression
of Ppargc1b, Htr1a, and Htr6 in the brain, and of Ppargc1a
and Ppargc1b in the liver were similar in both genotypes
and were not affected by WD, which might indicate ceiling
effects of complete or partial Sert deficiency on these receptors.
Earlier studies revealed a lowered Htr1a receptor expression
in the dorsal raphe region of female Sert−/− and Sert+/−
mice that was not found in the hypothalamus or hippocampus
(Li et al., 2000). Altered function of 5-HT1A and 5-HT6
are known to underlie depressive-like behaviors (Savitz
et al., 2009; Wesołowska, 2010), cognitive (Mitchell and
Neumaier, 2005; Ögren et al., 2008) and social (Meneses, 2001;
Wang et al., 2013) abnormalities, and may contribute to the
behavioral changes observed here. One can suggest that the
greater reduction in brain Ppargc1b expression in mutants
than in controls could be associated with more pronounced
obesity in the mutants.
Similar to the changes in the expression of serotonin receptors
induced by WD reported here were previously reported.
For example, cafeteria and high-energy diets decreased brain
expression of Htr2c receptor in rats (Lopez-Esparza et al., 2015;
Beilharz et al., 2018). Mice exposed to high-fat diet displayed
changes in the expression of Htr2a in the olfactory nucleus
and of Htr2c in the medial amygdaloid nucleus (Huang et al.,
2004). The 5-HT2C and 5-HT1B receptors were shown to play
an inhibitory role in the regulation of calorie intake, while
elevated gene expression in the hypothalamus was proposed as a
compensatory mechanism of hyperphagia in Ay mice (Nonogaki
et al., 2006). The 5-HT1B receptor was found to regulate food
intake and insulin receptor sensitivity in mice with genetic
inactivation of 5-HT2C receptor (Lee et al., 1998; Simansky
and Nicklous, 2002). In keeping with our results, altered
expression of 5-HT2C receptor was associated with obesity,
abnormal feeding behavior (Heisler et al., 1998), as well as insulin
resistance and elevated blood glucose concentrations (Zhou et al.,
2007). Finally, 5-HT6 receptor ligands were demonstrated to
improve insulin receptor sensitivity and regulate blood insulin,
glucose concentrations, mechanisms of satiety, and body weight
(Heal et al., 2008).
Remarkably, unlike WT controls and Sert−/− mice, Sert+/−
mice did not exhibit the principal hallmarks of the WD-
induced syndrome, such as decreases in glucose tolerance
and brain expression of Tlr4, and disrupted hippocampus-
dependent performance. In contrast to Sert−/−, they showed
no changes in the brain expression of Ppargc1a, Htr2a,
Htr1b, and Htr1c receptors, decreases in calories and water
intake, fasting glucose concentration, as well as novelty
hypoexploration and impulsive-like behavior in the elevated
O-maze. Thus, Sert+/− mice were seemingly quite different
from the Sert−/− genotype consequences following the WD
challenge and exhibited partial “resilience” to its negative
effects on the metabolic parameters and associated changes.
This is generally in line with previous findings suggesting
distinct physiology of two genotypes, as has been shown
for the expression of HPA regulatory protein-binding protein
5 (FK506) in the pituitary of mice exposed to early life
stress model (van der Doelen et al., 2014) and reduced
basal corticosterone plasma levels and improved memory
performance in the object recognition test in Sert+/− mice
(van den Hove et al., 2011).
Relative “resilience” of Sert+/− mice to the diet might be
viewed as an improved ability to adjust to environmental changes
associated with this genotype (Belsky et al., 2009). It is also
observed in clinical studies that showed beneficial effects of
heterozygosity of SERT, such as higher cognitive function in
elderly adults (Fiedorowicz et al., 2007) and other differences
(van Dyck et al., 2005; Malmberg et al., 2008) and generally
greater fitness in heterozygotes, because they show a broader
range of gene expression than both homozygotes (Comings and
MacMurray, 2000; Homberg and Lesch, 2011). This phenomenon
is also discussed in the framework of heterosis (Sonuga-Barke
et al., 2011), or outbreeding enhancement, i.e., the improved or
increased function of any biological quality in a hybrid offspring
(Shull, 1948).
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While our interpretation of the data might be considered
speculative, the results encourage further research to explore their
contribution of heterosis to the resilience phenotype.
CONCLUSION
The comparison of the effects of the WD in Sert−/−
mice Sert+/− reveals an intricate interplay between SERT
deficiency and regulation of metabolism during aging. Thus,
complete versus partial genetic SERT deficiency in aged mice
is associated with distinct metabolic, molecular, and behavioral
consequences following the WD challenge. While some diet-
induced changes were similar in the KO-WD and HET-WD mice,
the latter displayed a “rescued” phenotype in terms of dietary-
induced decrease in glucose tolerance, neuroinflammation, and
hippocampus-dependent behavior. SERT deficiency was found to
enhance inflammatory processes (Haub et al., 2010), and null-
mutant Sert mice demonstrate higher susceptibility to the effects
of WD on Tlr4 expression.
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